My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
A new UC San Francisco-led study brings scientists closer to understanding the causes of a mysterious rash of cases of acute severe hepatitis that began appearing in otherwise healthy children…
Scientists from the Institut Pasteur, Necker-Enfants Malades Hospital (AP-HP), Inserm in the Imagine Institute, Université Paris Cité and the Alfort National Veterinary School (EnvA) have identified a previously unknown species…
https://youtu.be/XmR5ecMT2Kc Given that protein aggregates in liver cells are closely linked to alcoholic liver disease, these findings suggest that quercetin could be a useful treatment for patients with this condition.…
Public release date: 10-Nov-2011 Acute alcoholic hepatitis is one of the most serious forms of alcoholic liver disease, affecting individuals with chronic excessive alcohol consumption, which generally equates to more…
Public release date: 7-Jun-2011 Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of…
Drinking tea, fruit juice or soft drinks not found to affect risk of cirrhosis death New research reveals that consuming two or more cups of coffee each day reduces the…
- shown that quercetin, a plant-derived bioflavonoid used by some as a nutritional supplement, attenuates Hepatitis C virus production with no cell toxicity Public release date: 12-Apr-2011 …
Contact: Dawn Peters sciencenewsroom@wiley.com 781-388-8408 Wiley Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication. Findings published…
Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment.…
Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment.…
Contact: Dawn Peters medicalnews@wiley.com 781-388-8408 Wiley-Blackwell Study finds caffeine in sources other than coffee does not have similar effect Researchers from the National Institute of Diabetes and Digestive and Kidney…
Contact: Kim Irwin kirwin@mednet.ucla.edu 310-206-2805 University of California - Los Angeles Health Sciences Natural compound blocks hepatitis C infection Finding may lead to a new treatment Researchers have identified two…
Public release date: 25-Sep-2008 Re-Posted for Filing Contact: Rachel Seroka rseroka@aan.com 651-695-2738 American Academy of Neurology Majority of children vaccinated against hepatitis B not at increased risk of MS ST.…
Finding may lead to a new treatment Researchers have identified two cellular proteins that are important factors in hepatitis C virus infection, a finding that may result in the approval…
Contact: Sue McGreevey smcgreevey@partners.org 617-724-2764 Massachusetts General Hospital MGH study reveals mechanism key to maintaining chronic infection, potential therapy target A compound that naturally occurs in grapefruit and other citrus…
Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven’t responded to previous attempts to eradicate the disease,…
Contact: Lixin Zhu wjg@wjgnet.com 86-108-538-1892 World Journal of Gastroenterology Who will recover spontaneously from hepatitis C virus infection More than 3% of world population is infected with hepatitis C virus…
Public release date: 4-Jan-2010 - "Quercetin may allow for the dissection of the viral life cycle and has potential therapeutic use to reduce virus production with low associated toxicity," …
Public release date: 20-Oct-2009 Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of…
Public release date: 4-Dec-2008 - researchers found no difference in the rate of progression of liver disease among patients who received interferon and those who did not DALLAS — Dec.…
You must be logged in to post a comment.